The Gross Margin of CASI Pharmaceuticals Inc (CASI) is 59.19%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2023-12-31 | 59.19% |
| 2022-12-31 | 63.28% |
| 2021-12-31 | 58.38% |
| 2020-12-31 | 37.20% |
| 2019-12-31 | 4.74% |